Smith & Nephew AGM not to be attended in person

Medical equipment manufacturer

Smith & Nephew plc (LON:SN), the global medical technology business, has today announced the following changes to the format of its Annual General Meeting to be held at 2:00pm on Thursday, 9 April 2020.

Further to UK Government instructions issued on Monday, 23 March 2020 and the closure of the venue until further notice, Shareholders must not attend the AGM in person.

The AGM will be convened with the minimum necessary quorum of two shareholders (which will be facilitated by Smith+Nephew). All valid proxy votes (whether submitted electronically or in hard copy form) will be included in the poll to be taken at the meeting.

Shareholders are urged to register their proxy appointment electronically via Smith+Nephew’s Registrar’s website at www.investorcentre.co.uk/eproxy by 2.00pm on Tuesday, 7 April 2020. If shareholders prefer to return a hard copy Form of Proxy, they should do so in accordance with the instructions on the Form, which was distributed with the Notice of Meeting. Where necessary, you should contact the registered shareholder (the custodian or broker) who looks after your investments in the Company on your behalf, in order to vote your shares.

The Board recommends voting in favour of all the resolutions contained in the Notice of AGM as, in the Board’s opinion, they are in the best interests of the Company and its shareholders as a whole.

The Board understands that beyond voting on the formal business of the meeting, the AGM also serves as a forum for shareholders to raise questions and comments to the Board.

Therefore, following the AGM, the Board will hold an Audiocast meeting at 3:00pm on Thursday, 9 April 2020 for registered shareholders and their corporate representatives or proxies. This will include a short presentation from Roland Diggelmann, Chief Executive Officer and then Roberto Quarta, Chair of Smith & Nephew plc, who will respond to questions submitted prior to the meeting.

Registered shareholders may submit their questions by email to [email protected].

The dial-in and login details in order to attend the Audiocast meeting are being sent directly to registered shareholders.

The presentation will also be available on the Smith+Nephew website after the meeting.

Share on:

Latest Company News

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named.

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery.

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance.

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program.

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership.

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%.

    Search